article · JMIR Formative Research

Long-Term Experiences of Health Care Providers Using Iris Scanning as an Identification Tool in a Vaccine Trial in the Democratic Republic of the Congo: Qualitative Study

Trésor Zola Matuvanga
Gwen Lemey
Vivi Maketa
Junior Matangila
Maha Salloum
Pierre Van Damme
Ynke Larivière
Bernard Isekah Osang’ir
Antea Paviotti
Emmanuel Esanga Longomo
Solange Milolo
Hypolite Muhindo Mavoko
Freddy Bikioli Bolombo
Patrick Mitashi
Jean‐Pierre Van Geertruyden

2024Open accessUniversité de Kinshasa (UNIKIN)

Abstract

Our findings highlight the sustained acceptability and perceived high accuracy of the iris scan tool for uniquely identifying adult participants in a vaccine trial over time. Continued efforts to systematically disseminate and reinforce information about the function and safety of this technology are essential. Clearly presenting iris scanning as a safe procedure could help dispel misconceptions, concerns, and perceived risks among potential users in vaccine trials.

Research topics

Biometric Identification and Security
Pharmaceutical Quality and Counterfeiting

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.2196/54921

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.